VectivBio
VECT
$16.85
Share price
0.00%
Change (1 day)
206.92%
Change (1 year)
Categories
Revenue for VectivBio (VECT)
Revenue in 2022: $27.34 M
According to VectivBio's latest financial reports the company's current revenue (TTM
) is $27.34 M.
In 2022 the company made a revenue of $27.34 M an increase over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for VectivBio from 2019 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 | $27.34 M | |
| 2021 | N/A | |
| 2020 | N/A | |
| 2019 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $0.24 M | -99.11% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $21.83 M | -20.12% | 🇬🇧 UK |
 Novavax NVAX | $0.69 B | 2,436.34% | 🇺🇸 USA |
 Novocure
NVCR | $0.50 B | 1,762.91% | Jersey |